Insider Buying Signals a Confidence Boost for Movano Inc. Cullinan Brian, a long‑standing shareholder, granted himself 7,748 restricted stock units (RSUs) on January 9 2026, adding to his holding of 9,622 RSUs and bringing his total post‑transaction stake to 9,622 RSUs plus 4,768 RSUs = 14,390 RSUs. The grant, valued at $0.00 per share (as RSUs are non‑cash compensation), reflects a strategic move by the board to align executive incentives with the company’s long‑term growth. In a market where Movano’s shares have slumped 87.7 % year‑to‑date, this insider action sends a cautiously optimistic signal: those who know the business best are betting on a rebound.
What the Deal Means for Investors The transaction coincided with a slight dip in the stock price (-0.07 %) and a spike in social‑media buzz (1,472 % of average). Such timing suggests insiders are taking advantage of temporary pricing inefficiencies, buying before a potential upside. Coupled with the company’s high 52‑week low of $4.67 and current price of $7.49, the RSU grant can be seen as a bullish endorsement. Investors may interpret this as a sign that Movano’s management believes its wearable‑RF platform will start to translate into revenue growth, especially as the firm navigates its recent trading pause and re‑enters the market.
Cullinan Brian’s Historical Trading Pattern Reviewing Brian’s prior filings shows a pattern of large, cumulative purchases: 35,500 shares in November 2025, 33,096 in October 2025, 29,851 in July 2025, and 69,767 in May 2025. These buys have consistently increased his stake from 1,874 to 151,452 shares, indicating a long‑term view rather than short‑term speculation. The recent RSU grants continue this trend of aligning his compensation with equity, reinforcing his confidence in the company’s trajectory. His past sales (e.g., 13,271 shares sold in November 2025) appear to be opportunistic rather than reactionary, suggesting a disciplined approach to portfolio management.
Company‑Wide Insider Activity Context While Brian’s RSU grant is significant, other key insiders have been active as well. CFO Jeremy Cogan executed six trades on January 9 2026, buying 9,299 shares after selling large blocks in early January. CTO Michael Aaron sold a combined 8,145 shares in early January, likely to fund other ventures or diversify holdings. CEO John Mastrototaro has been largely passive, with few large transactions. The mix of buying and selling across the leadership team indicates a balanced view: while executives are harvesting liquidity, they are also investing back into the company, a common pattern in tech firms awaiting a market turnaround.
Implications for the Future The RSU grant, combined with a spike in social‑media sentiment (+96) and high buzz, positions Movano as a candidate for a “bottom‑pull” scenario. If the company delivers on its wearable‑RF platform—potentially capturing a growing health‑tech market—shares could rally from the current $7.49 level toward the 52‑week high of $58.76. Investors should, however, remain cautious: the negative P/E ratio (-0.328) and steep year‑to‑date decline underscore ongoing valuation concerns. Yet the insider confidence, reflected in Brian’s consistent buying and the board’s incentive structure, provides a tangible anchor for those evaluating whether to add or hold shares during this consolidation phase.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-01-09 | Cullinan Brian () | Buy | 4,768.00 | N/A | Common Stock |
| 2026-01-09 | Cullinan Brian () | Buy | 2,980.00 | N/A | Common Stock |
| 2026-01-09 | FAIRBAIRN EMILY () | Buy | 4,470.00 | N/A | Common Stock |
| 2026-01-09 | FAIRBAIRN EMILY () | Buy | 5,959.00 | N/A | Common Stock |
| N/A | FAIRBAIRN EMILY () | Holding | 33,232.00 | N/A | Common Stock |
| N/A | FAIRBAIRN EMILY () | Holding | 3,522.00 | N/A | Common Stock |
| 2026-01-09 | Wirk Shaheen () | Buy | 2,980.00 | N/A | Common Stock |
| 2026-01-09 | Wirk Shaheen () | Buy | 2,980.00 | N/A | Common Stock |
| 2026-01-09 | Caballero Ruben () | Buy | 2,980.00 | N/A | Common Stock |
| 2026-01-09 | Caballero Ruben () | Buy | 2,980.00 | N/A | Common Stock |
| 2026-01-06 | Leabman Michael Aaron (Chief Technology Officer) | Buy | 42,250.00 | 1.25 | Common Stock |
| 2026-01-07 | Leabman Michael Aaron (Chief Technology Officer) | Sell | 3,293.00 | 7.34 | Common Stock |
| 2026-01-08 | Leabman Michael Aaron (Chief Technology Officer) | Sell | 3,593.00 | 7.26 | Common Stock |
| 2026-01-09 | Leabman Michael Aaron (Chief Technology Officer) | Sell | 783.00 | 7.27 | Common Stock |
| 2026-01-06 | Leabman Michael Aaron (Chief Technology Officer) | Sell | 42,250.00 | 0.00 | Stock Options (Right to Buy) |
| 2026-01-05 | Cogan Jeremy (CFO) | Buy | 20,000.00 | 1.25 | Common Stock |
| 2026-01-05 | Cogan Jeremy (CFO) | Sell | 1,879.00 | 8.35 | Common Stock |
| 2026-01-06 | Cogan Jeremy (CFO) | Sell | 3,859.00 | 8.03 | Common Stock |
| 2026-01-06 | Cogan Jeremy (CFO) | Sell | 4,359.00 | 7.57 | Common Stock |
| 2026-01-09 | Cogan Jeremy (CFO) | Buy | 9,299.00 | N/A | Common Stock |
| 2026-01-05 | Cogan Jeremy (CFO) | Sell | 20,000.00 | 0.00 | Stock Options (Right to Buy) |




